Inhalation Sciences Sweden AB Stock Börse Stuttgart
Stocks
SE0009983893
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 06-16 | Inhalation Sciences Secures SEK 0.4m Research Grant | FW |
| 05-29 | Inhalation Sciences continues to evaluate sale – issues fresh warning over funding shortfall | FW |
| Market Cap | 12.29M 1.26M 1.11M 1.02M 953K 1.79M 119M 1.84M 4.74M 58.92M 4.74M 4.64M 205M | P/E 2024 |
-12.8x | P/E 2025 | -12.4x |
|---|---|---|---|---|---|
| Enterprise Value | 9.46M 972K 851K 786K 734K 1.38M 91.91M 1.41M 3.65M 45.34M 3.65M 3.57M 157M | EV / Sales 2024 |
5.6x | EV / Sales 2025 | 55x |
| Free-Float |
94.25% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Manoush Masarrat
CEO | Chief Executive Officer | - | 16/09/2019 |
Per Magnus Gerde
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2005 |
Ulf Wedenberg
PRN | Corporate Officer/Principal | - | 02/06/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Per Magnus Gerde
BRD | Director/Board Member | - | 01/01/2005 |
Jan Hellqvist
BRD | Director/Board Member | - | 01/09/2022 |
Ulf Ericsson
BRD | Director/Board Member | - | 01/09/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 1.26M | |
| -1.29% | +9.14% | +24.04% | -1.55% | 188B | |
| +0.31% | +0.75% | -23.93% | +19.94% | 144B | |
| -1.74% | +8.19% | -3.03% | -18.92% | 136B | |
| -1.70% | -1.92% | -59.19% | -18.41% | 64.63B | |
| +0.44% | +6.17% | +16.58% | -0.91% | 52.5B | |
| +0.90% | -0.64% | -27.11% | -33.86% | 43.4B | |
| -2.34% | +5.01% | +11.46% | +12.52% | 37.52B | |
| -1.48% | +2.96% | +4.67% | +40.82% | 36.22B | |
| -1.08% | +7.27% | -12.54% | -17.32% | 29.59B | |
| Average | -0.19% | +4.47% | -7.67% | -1.97% | 81.36B | |
| Weighted average by Cap. | -0.52% | +5.68% | -4.42% | -1.75% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 11.05M 1.14M 994K 918K 857K 1.61M 107M 1.65M 4.26M 52.97M 4.26M 4.17M 184M | 3.04M 313K 274K 253K 236K 444K 29.56M 454K 1.17M 14.58M 1.17M 1.15M 50.63M |
| Net income | -5.15M -529K -463K -428K -399K -752K -50.03M -769K -1.99M -24.68M -1.99M -1.94M -85.69M | -10.16M -1.04M -915K -844K -788K -1.48M -98.75M -1.52M -3.92M -48.72M -3.92M -3.84M -169M |
| Net Debt | -4M -412K -360K -333K -311K -585K -38.91M -598K -1.55M -19.19M -1.55M -1.51M -66.64M | -2.83M -291K -255K -235K -220K -414K -27.52M -423K -1.09M -13.57M -1.09M -1.07M -47.13M |
Employees
5
Net sales - Rate of surprise
Select your edition
All financial news and data tailored to specific country editions
